Foundation University College of Physical Therapy
Islamabad, 44000, Pakistan
Location status: Recruiting
Recruiting
NCT Number: NCT07006402
Effects of Reverse Natural Apophyseal Glides as Compared to Ventro-cranial Translatoric Glides in the Management of Upper Thoracic Spine Hypomobility.
This study is a randomized controlled trial and the purpose of the study is to determine the effects of reverse NAGs as compared to Ventro-cranial Translatoric Glides in upper thoracic spine hypomobility in terms of pain and range of motion.
Recruiting
Interested in participating?
Request InfoKey information
Conditions
Age range
18 year–39 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
About this study
OBJECTIVES:
The objectives of this study are :
- To determine the effects of reverse NAGs as compared to ventrocranial translatoric glide on UPPER BACK PAIN in upper thoracic spine hypomobility.
- To determine the effects of reverse NAGs as compared to ventrocranial translatoric glide on THORACIC ROM in upper thoracic spine hypomobility.
HYPOTHESIS:
Alternate Hypothesis:
- There will be a statistically significant difference in the effects of reverse NAGs as compared to ventrocranial translatoric glides in terms of upper back pain in persons with upper thoracic hypo mobility (p<0.05).
- There will be a statistically significant difference in the effects of reverse NAGs as compared to ventrocranial translatoric glides in terms of thoracic ROM in persons with upper thoracic hypo mobility (p<0.05).
NULL HYPOTHSIS :
- There will be no statistically significant difference in the effects of reverse NAGs as compared to ventrocranial translatoric glides in terms of upper back pain in persons with upper thoracic hypo mobility (p>0.05).
- There will be no statistically significant difference in the effects of reverse NAGs as compared to ventrocranial translatoric glides in terms of thoracic ROM in persons with upper thoracic hypo mobility (p>0.05).
RESEARCH DESIGN : Experimental study .Randomized control trail.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- 1. Both male and females 2. Adults (18-39 years) 3. Upper Thoracic hypomobility (flexion <20° or extension <25° or side bending <20° or rotation <35°)
Exclusion criteria
- 1-Ankylosing spondylitis 2-History of Spinal Fusion or spinal surgery (discectomy/laminectomy etc.) 3-Degenerative disc disorders 4-Cervical radiculopathy, Scoliosis 5-Spinal Stenosis or Myelopathy 6-Recent fracture or surgery 7-TB of spine, Spondylolisthesis 8-Not able to attend regular therapy appointments 9-Fibromyalgia/myofascial pain syndrome
Treatment and study plan
Reverse NAGS(experimental)
ProcedureAll participants will receive 2 weeks of intervention with a frequency of 3-4 days/week with a period of rest in between. 20 minutes of TENS+ hot pack will be given followed by Reverse NAGs on hypomobile segments at level T1-T4.
In these type of mobilization, the inferior facet glides up on the superior. The mobilizations are repeated <6 times and then movements are reassessed. If no change occurs, the process will be repeated upto 10 minutes with resting period.
Grade III Ventro-Cranial Translatoric Glides(standard protocol)
ProcedureAll participants will receive 2 weeks of intervention with a frequency of 3-4 days/week with a period of rest in between. 20 minutes of TENS+ hot pack will be given followed by Grade III Ventro-Cranial Translatoric Glides on hypomobile segments at level T1-T4.
The mobilization will be applied and sustained for 30-40 seconds and will be continued for 10-15 minutes in a cyclic manner.
The grades of mobilization will be tapered as per individual needs.
Primary outcomes
-
Thoracic Pain
Time frame: Variable will be assessed at pre and post treatment for the total interval of 2 weeks.
It will be measured using numeric pain rating scale (NPRS) in which the subjects select a number ranging from 0-10 according to their intensity of pain. '0' score indicates no pain while '10' indicates worst pain experienced.
-
Range of Motion
Time frame: Variable will be assessed at pre and post treatment for the total interval of 2 weeks.
Range of motion will be measured using inclinometer. It will be used to measure range of motion of flexion, extension and lateral flexion on both right and left side on thoracic spine.
Study contacts
Contact information is provided by the study sponsor or research team.
Sponsors and collaborators
Lead sponsor
Foundation University Islamabad
Other
Registry information
Important dates
- Study start
- 2024
- Primary completion
- 2025
- Study completion
- 2025
- First posted
- Jun 5, 2025
- Registry last updated
- Jun 5, 2025
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.